Observational studyMedicine2025
Influence of infrapatellar fat pad size on the development and severity of chondromalacia patella.
Observational study in Medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The inflammatory role of the infrapatellar fat pad (IPFP) in cartilage damage has been well-documented, yet its potential protective function as a shock absorber remains underexplored. This retrospective cohort study aimed to evaluate the relationship between the IPFP size and chondromalacia patella (CP), while also examining the effects of age, sex, and body mass index (BMI). Magnetic resonance imaging scans from 311 patients aged 40 to 65 years were retrospectively analyzed. Axial sequences classified CP severity, and sagittal sequences measured IPFP areas. CP was graded according to the International Cartilage Repair Society system, and patients were grouped into control (no CP), mild CP (grades 1-2), and severe CP (grades 3-4) categories. Demographic data, including age, sex, and BMI, were collected, and statistical analysis explored the relationships between IPFP area, CP severity, and these factors. Of the patients, 145 (46.6%) had no CP, while 166 (53.4%) had varying CP severity. Patients with CP had significantly smaller IPFP areas (6.16 ± 0.67 cm2) compared to controls (6.96 ± 0.87 cm2, P < .001). The mean IPFP area decreased progressively with increasing CP severity. After adjusting for confounders, a smaller IPFP area was significantly associated with the presence and severity of CP (P < .001). These findings provide evidence that a larger IPFP area plays a protective role in maintaining patellar cartilage integrity and mitigating CP progression, as demonstrated by a significant inverse correlation between IPFP area and CP severity, independent of age, sex, and BMI. A comprehensive, multidisciplinary approach integrating biomechanical, metabolic, and inflammatory factors is warranted to fully elucidate the role of IPFP in CP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.